SET domain-containing protein 4 (SETD4) is a newly identified cytosolic and nuclear lysine methyltransferase involved in breast cancer cell proliferation

Journal of Cancer Science and Therapy

Volumn 5, Issue 2, 2013, Pages 058-065

  Faria, Jerusa Araújo Quintão Arantes ^a   Corrêa, Natássia Caroline Resende ^a   de Andrade, Carolina ^a   Campos, Ana Carolina de Angelis ^a   de Almeida, Rubens dos Santos Samuel ^b   Rodrigues, Thiago Souza ^c   de Goes, Alfredo Miranda ^a   Gomes, Dawidson Assis ^a   Silva, Fábio Pittella ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c CENTRO FEDERAL DE EDUCAÇÃO TECNOLÓGICA DE MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HISTONE LYSINE METHYLTRANSFERASE; PROGESTERONE RECEPTOR; SET DOMAIN CONTAINING PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DENSITOMETRY; DNA MICROARRAY; FAR WESTERN BLOTTING; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84874199912     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000185     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692.
3. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080.
4. Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S (2011) Epigenetics in breast cancer: what's new? Breast Cancer Res 13: 225.
5. Dillon SC, Zhang X, Trievel RC, Cheng X (2005) The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 6: 227.
6. Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, et al. (2002) Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 12: 1052-1058.
7. Zhang X, Wen H, Shi X (2012) Lysine methylation: beyond histones. Acta Biochim Biophys Sin (Shanghai) 44: 14-27.
8. Albert M, Helin K (2010) Histone methyltransferases in cancer. Semin Cell Dev Biol 21: 209-220.
9. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, et al. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6: 731-740.
10. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-1043.
11. Marchler-Bauer A, Bryant SH (2004) CD-Search: protein domain annotations on the fly. Nucleic Acids Res 32: W327-331.
12. Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, et al. (2008) The Pfam protein families database. Nucleic Acids Res 36: D281-288.
13. Eswar N, Eramian D, Webb B, Shen MY, Sali A (2008) Protein structure modeling with MODELLER. Methods Mol Biol 426: 145-159.
14. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM (1992) Stereochemical quality of protein structure coordinates. Proteins 12: 345-364.
15. Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35: W407-410.
16. Ordog R (2008) PyDeT, a PyMOL plug-in for visualizing geometric concepts around proteins. Bioinformation 2: 346-347.
17. Correa CR, Bertollo CM, Goes AM (2009) Establishment and characterization of MACL-1 and MGSO-3 cell lines derived from human primary breast cancer. Oncol Res 17: 473-482.
18. Speirs V, White MC, Green AR (1996) Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Dev Biol Anim 32: 72-74.
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
21. Cui X, Churchill GA (2003) Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 4: 210.
22. De Angelis Campos AC, Rodrigues MA, de Andrade C, de Goes AM, Nathanson MH, et al. (2011) Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. Biochem Biophys Res Commun 412: 341-346.
23. Gomes DA, Rodrigues MA, Leite MF, Gomez MV, Varnai P, et al. (2008) c-Met must translocate to the nucleus to initiate calcium signals. J Biol Chem 283: 4344-4351.
24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
25. Trievel RC, Flynn EM, Houtz RL, Hurley JH (2003) Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT. Nat Struct Biol 10: 545-552.
26. Marmorstein R (2003) Structure of SET domain proteins: a new twist on histone methylation. Trends Biochem Sci 28: 59-62.
27. Zhang X, Tamaru H, Khan SI, Horton JR, Keefe LJ, et al. (2002) Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell 111: 117-127.
28. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
29. Corrêa NCR, Kuasne H, Faria JAQA, Seixas CCS, Santos IGD, et al. (2012) Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors. Oncology Reports. In Press.
30. Petrossian TC, Clarke SG (2011) Uncovering the human methyltransferasome. Mol Cell Proteomics 10: M110.
31. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100: 11606-11611.
32. Su IH, Dobenecker MW, Dickinson E, Oser M, Basavaraj A, et al. (2005) Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 121: 425-436.
33. Kunizaki M, Hamamoto R, Silva FP, Yamaguchi K, Nagayasu T, et al. (2007) The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res 67: 10759-10765.
34. Gonzalez ME, Li X, Toy K, DuPrie M, Ventura AC, et al. (2009) Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene 28: 843-853.
35. Cho HS, Hayami S, Toyokawa G, Maejima K, Yamane Y, et al. (2012) RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. Neoplasia 14: 476-486.